Rocket Pharmaceuticals, Inc. (RCKT)
2.26
+0.08
(+3.67%)
USD |
NASDAQ |
Oct 19, 14:45
Rocket Pharmaceuticals Cash from Operations (Annual) : -190.05M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -190.05M |
| December 31, 2024 | -209.82M |
| December 31, 2023 | -195.06M |
| December 31, 2022 | -178.31M |
| December 31, 2021 | -121.36M |
| December 31, 2020 | -80.20M |
| December 31, 2019 | -64.66M |
| Date | Value |
|---|---|
| December 31, 2018 | -53.79M |
| December 31, 2017 | -15.96M |
| December 31, 2016 | -37.27M |
| December 31, 2015 | -17.42M |
| December 31, 2014 | -9.743M |
| December 31, 2013 | -6.455M |
| December 31, 2012 | -6.936M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | -222.54M |
| Intellia Therapeutics, Inc. | -394.74M |
| Beam Therapeutics, Inc. | -345.10M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |